Kiniksa Pharmaceuticals International, plc KNSA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported operating lease right-of-use assets in other assets of $9.33M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets decreased by 10.7% year-over-year, from $10.45M to $9.33M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's operating lease right-of-use assets in other assets has grown at a 8.4% compound annual growth rate (CAGR), from $6.57M to $9.81M.